Parkinson disease trials in Australia

In Australia 9 Also abroad 823

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Where
Clayton, Kogarah, Nedlands, Parkville, Prahan, Westmead, Woolloongabba
Age
50 years to 85 years
People
900 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Where
Clayton, Melbourne, Parkville, Randwick, Southport, Woolloongabba
Age
45 years to 75 years
People
102 worldwide
Run by
BlueRock Therapeutics
See details and how to joinNCT06944522
Phase 1Taking people
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.
Where
Adelaide, Melbourne
Age
18 years to 75 years
People
106 worldwide
Run by
Mission Therapeutics
See details and how to joinNCT07630545 · EU 2024-517310-15-01
Phase 1Taking people
A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease.
Where
Melbourne
Age
30 years to 89 years
People
64
Run by
Longevity Biotech Australia Pty Ltd (subsidiary)
See details and how to joinNCT06466525
Phase 1Taking people
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
Where
Adelaide, Melbourne
Age
40 years to 80 years
People
40 worldwide
Run by
Serina Therapeutics
See details and how to joinNCT07422675
No phaseTaking people
Retinal Hyperspectral Imaging in Neurodegenerative Diseases
Where
Melbourne
Age
30 years and over
People
930
Run by
Center for Eye Research Australia
See details and how to joinNCT07545473
No phaseTaking people
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Where
Parkville, Woolloongabba
People
1,000 worldwide
Run by
Abbott Medical Devices
See details and how to joinNCT04071847
No phaseTaking people
Steps Against the Burden of Parkinson's Disease
Where
Randwick
Age
18 years and over
People
42
Run by
The University of New South Wales
See details and how to joinNCT07057219
Phase 1Taking people
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease
Where
Adelaide, Darlinghurst, Kogarah, Melbourne, Parkville, Westmead, Woolloongabba
Age
30 years to 85 years
People
20
Run by
Gain Therapeutics, Inc.
See details and how to joinNCT06732180